Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1492450

Cover Image

PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1492450

Europe Pediatric Perfusion Market Size- By Product, By Applications, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

PUBLISHED:
PAGES: 154 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3400
PDF (Group License)
USD 4520
PDF (Company License)
USD 5650

Add to Cart

Europe Pediatric Perfusion Market Introduction and Overview

According to SPER Market Research, 'Europe Pediatric Perfusion Market Size- By Product, By Application, By End Use- Regional Outlook, Competitive Strategies and Segment Forecast to 2033' states that the Europe Pediatric Perfusion Market is estimated to reach USD XX Billion by 2033 with a CAGR 5.81%

Blood is given via the circulatory system to children undergoing cardiopulmonary bypass (CPB) during open heart surgery, a procedure known as paediatric perfusion. In order to preserve lung gas exchange and circulation while the patient's heart is halted for specialized surgical repair procedures, CPB entails redirecting the patient's blood flow through a heart-lung machine. Since juvenile and adult patients differ anatomically and physiologically, paediatric perfusion calls for specific tools, methods, and expertise.

Due to interruptions in the treatments for juvenile cardiac operations, the COVID-19 pandemic had a detrimental effect on the paediatric perfusion systems industry. The delay in elective procedures especially cardiovascular treatments for children led to a decrease in the need for perfusion systems in the early stages of the epidemic. Hospitals dispersed resources to handle the increase in COVID-19 cases, which decreased the availability and usage of paediatric perfusion systems.

Scope of the Report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Product, By Application, By End-Use

Regions covered Eastern Europe, Southern Europe, Western Europe, and Northern Europe

Companies Covered BL Lifesciences, Cardinal Health, Inc., EUROSETS S.R.L. (GVM Care Research), GE HealthCare Technologies, Inc., Getinge AB, Koninklijke Philips N.V., LivaNova PLC, Medtronic PLC, Nonin Medical, Inc., and Terumo Corporation.

Europe Pediatric Perfusion Market Key Segments Covered

By Product: Based on the Product, Europe Pediatric Perfusion Market is segmented as; Oxygenators, Cannulas and Catheters, Blood Pumps, Arterial Filters

By Application: Based on the Application, Europe Pediatric Perfusion Market is segmented as; Cardiac Surgeries, Organ Transplantation.

By End-Use: Based on the End-Use, Europe Pediatric Perfusion Market is segmented as; Hospitals, Cardiac Centers.

By Region: This research also includes data for Eastern Europe, Southern Europe, Western Europe, and Northern Europe.

Product Code: HLCA2459

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPER's internal database
    • 2.1.4. Premium insight from KOL's
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
  • 4.2. COVID-19 Impacts of the Europe Pediatric Perfusion Market.

5. Market variable and outlook

  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTER's Five Forces
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis

6. Competitive Landscape

  • 6.1. Europe Pediatric Perfusion Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Europe Pediatric Perfusion Market

7. Europe Pediatric Perfusion Market, By Product (USD Million) 2020-2033

  • 7.1. Europe Pediatric Perfusion Market Size, Share and Forecast, By Product, 2020-2026
  • 7.2. Europe Pediatric Perfusion Market Size, Share and Forecast, By Product, 2027-2033
  • 7.3. Oxygenators
  • 7.4. Cannulas and Catheters
  • 7.5. Blood Pumps
  • 7.6. Arterial Filters

8. Europe Pediatric Perfusion Market, By Application (USD Million) 2020-2033

  • 8.1. Europe Pediatric Perfusion Market Size, Share and Forecast, By Application, 2020-2026
  • 8.2. Europe Pediatric Perfusion Market Size, Share and Forecast, By Application, 2027-2033
  • 8.3. Cardiac Surgeries
  • 8.4. Organ Transplantation

9. Europe Pediatric Perfusion Market, By End-Use (USD Million) 2020-2033

  • 9.1. Europe Pediatric Perfusion Market Size, Share and Forecast, By End-Use, 2020-2026
  • 9.2. Europe Pediatric Perfusion Market Size, Share and Forecast, By End-Use, 2027-2033
  • 9.3. Hospitals
  • 9.4. Cardiac Centers

10. Europe Pediatric Perfusion Market Forecast, 2020-2033 (USD Million)

  • 10.1. Europe Pediatric Perfusion Market Size and Market Share

11. Europe Pediatric Perfusion Market, By Region, 2020-2033 (USD Million)

  • 11.1. Europe Pediatric Perfusion Market Size and Market Share By Region (2020-2026)
  • 11.2. Europe Pediatric Perfusion Market Size and Market Share By Region (2027-2033)
  • 11.3. Eastern Europe
  • 11.4. Southern Europe
  • 11.5. Western Europe
  • 11.6. Northern Europe

12. Company Profile

  • 12.1. BL LIFESCIENCES
    • 12.1.1. Company details
    • 12.1.2. Financial outlook
    • 12.1.3. Product summary
    • 12.1.4. Recent developments
  • 12.2. CARDINAL HEALTH, INC
    • 12.2.1. Company details
    • 12.2.2. Financial outlook
    • 12.2.3. Product summary
    • 12.2.4. Recent developments
  • 12.3. EUROSETS S.R.L (GVM CARE RESEARCH)
    • 12.3.1. Company details
    • 12.3.2. Financial outlook
    • 12.3.3. Product summary
    • 12.3.4. Recent developments
  • 12.4. GE HEALTHCARE TECHNOLOGIES, INC
    • 12.4.1. Company details
    • 12.4.2. Financial outlook
    • 12.4.3. Product summary
    • 12.4.4. Recent developments
  • 12.5. GETINGE AB
    • 12.5.1. Company details
    • 12.5.2. Financial outlook
    • 12.5.3. Product summary
    • 12.5.4. Recent developments
  • 12.6. KONINKLIJKE PHILIPS N.V.
    • 12.6.1. Company details
    • 12.6.2. Financial outlook
    • 12.6.3. Product summary
    • 12.6.4. Recent developments
  • 12.7. LIVANOVA PLC
    • 12.7.1. Company details
    • 12.7.2. Financial outlook
    • 12.7.3. Product summary
    • 12.7.4. Recent developments
  • 12.8. MEDTRONIC PLC
    • 12.8.1. Company details
    • 12.8.2. Financial outlook
    • 12.8.3. Product summary
    • 12.8.4. Recent developments
  • 12.9. NONIN MEDICAL, INC
    • 12.9.1. Company details
    • 12.9.2. Financial outlook
    • 12.9.3. Product summary
    • 12.9.4. Recent developments
  • 12.10. TERUMO CORPORATION
    • 12.10.1. Company details
    • 12.10.2. Financial outlook
    • 12.10.3. Product summary
    • 12.10.4. Recent developments
  • 12.11. OTHERS

13. Conclusion

14. List of Abbreviations

15. Reference Links

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!